162 related articles for article (PubMed ID: 37774671)
1. Long non-coding RNAs and pancreatic cancer: A multifaceted view.
Bin Wang ; Yuan C; Qie Y; Dang S
Biomed Pharmacother; 2023 Nov; 167():115601. PubMed ID: 37774671
[TBL] [Abstract][Full Text] [Related]
2. Long Non-Coding RNAs in Pancreatic Cancer: Biologic Functions, Mechanisms, and Clinical Significance.
Li J; Hou S; Ye Z; Wang W; Hu X; Hang Q
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565245
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications.
Bravo-Vázquez LA; Frías-Reid N; Ramos-Delgado AG; Osorio-Pérez SM; Zlotnik-Chávez HR; Pathak S; Banerjee A; Bandyopadhyay A; Duttaroy AK; Paul S
Transl Oncol; 2023 Jan; 27():101579. PubMed ID: 36332600
[TBL] [Abstract][Full Text] [Related]
4. SNHG11: A New Budding Star in Tumors and Inflammatory Diseases.
Wu Y
Mini Rev Med Chem; 2023; 23(20):1993-2006. PubMed ID: 37165588
[TBL] [Abstract][Full Text] [Related]
5. LncRNAs in pancreatic cancer.
Huang X; Zhi X; Gao Y; Ta N; Jiang H; Zheng J
Oncotarget; 2016 Aug; 7(35):57379-57390. PubMed ID: 27429196
[TBL] [Abstract][Full Text] [Related]
6. Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance- A review.
Al-Noshokaty TM; Mansour A; Abdelhamid R; Abdellatif N; Alaaeldien A; Reda T; Abdelmaksoud NM; Doghish AS; Abulsoud AI; Elshaer SS
Pathol Res Pract; 2023 May; 245():154438. PubMed ID: 37043965
[TBL] [Abstract][Full Text] [Related]
7. The long coding RNA AFAP1-AS1 promotes tumor cell growth and invasion in pancreatic cancer through upregulating the IGF1R oncogene via sequestration of miR-133a.
Chen B; Li Q; Zhou Y; Wang X; Zhang Q; Wang Y; Zhuang H; Jiang X; Xiong W
Cell Cycle; 2018; 17(16):1949-1966. PubMed ID: 30300116
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA MACC1-AS1 promoted pancreatic carcinoma progression through activation of PAX8/NOTCH1 signaling pathway.
Qi C; Xiaofeng C; Dongen L; Liang Y; Liping X; Yue H; Jianshuai J
J Exp Clin Cancer Res; 2019 Aug; 38(1):344. PubMed ID: 31391063
[TBL] [Abstract][Full Text] [Related]
9. Role of Long Non-coding RNAs on Bladder Cancer.
Li HJ; Gong X; Li ZK; Qin W; He CX; Xing L; Zhou X; Zhao D; Cao HL
Front Cell Dev Biol; 2021; 9():672679. PubMed ID: 34422802
[TBL] [Abstract][Full Text] [Related]
10. Biological functions, mechanisms, and clinical significance of circular RNA in pancreatic cancer: a promising rising star.
Chen Q; Li J; Shen P; Yuan H; Yin J; Ge W; Wang W; Chen G; Yang T; Xiao B; Miao Y; Lu Z; Wu P; Jiang K
Cell Biosci; 2022 Jun; 12(1):97. PubMed ID: 35729650
[TBL] [Abstract][Full Text] [Related]
11. Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers.
Wang Y; Li Z; Zheng S; Zhou Y; Zhao L; Ye H; Zhao X; Gao W; Fu Z; Zhou Q; Liu Y; Chen R
Oncotarget; 2015 Nov; 6(34):35684-98. PubMed ID: 26447755
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
[TBL] [Abstract][Full Text] [Related]
13. Biological Function of Long Non-coding RNA (LncRNA) Xist.
Wang W; Min L; Qiu X; Wu X; Liu C; Ma J; Zhang D; Zhu L
Front Cell Dev Biol; 2021; 9():645647. PubMed ID: 34178980
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA XLOC_000647 suppresses progression of pancreatic cancer and decreases epithelial-mesenchymal transition-induced cell invasion by down-regulating NLRP3.
Hu H; Wang Y; Ding X; He Y; Lu Z; Wu P; Tian L; Yuan H; Liu D; Shi G; Xia T; Yin J; Cai B; Miao Y; Jiang K
Mol Cancer; 2018 Jan; 17(1):18. PubMed ID: 29386037
[TBL] [Abstract][Full Text] [Related]
15. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
16. Analysis of cuproptosis-related lncRNA signature for predicting prognosis and tumor immune microenvironment in pancreatic cancer.
Yao HF; Xu DP; Zheng JH; Xu Y; Jia QY; Zhu YH; Yang J; He RZ; Ma D; Yang MW; Fu XL; Liu DJ; Huo YM; Yang JY; Zhang JF
Apoptosis; 2023 Aug; 28(7-8):1090-1112. PubMed ID: 37079192
[TBL] [Abstract][Full Text] [Related]
17. Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding star.
Xu T; Lin CM; Cheng SQ; Min J; Li L; Meng XM; Huang C; Zhang L; Deng ZY; Li J
Mol Cancer; 2018 Jul; 17(1):103. PubMed ID: 30037351
[TBL] [Abstract][Full Text] [Related]
18. LncRNAs associated with vascular mimicry establish a novel molecular subtype and prognostic model for pancreatic cancer.
Li D; Zhang Q; Tang Y; Mao F; Zeng J; Ji A
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11571-11584. PubMed ID: 37400573
[TBL] [Abstract][Full Text] [Related]
19. Long Noncoding Competing Endogenous RNA Networks in Pancreatic Cancer.
Xiong G; Pan S; Jin J; Wang X; He R; Peng F; Li X; Wang M; Zheng J; Zhu F; Qin R
Front Oncol; 2021; 11():765216. PubMed ID: 34760707
[TBL] [Abstract][Full Text] [Related]
20. Research progress on long non-coding RNAs and their roles as potential biomarkers for diagnosis and prognosis in pancreatic cancer.
Wang Y; Zhou L; Lu J; Jiang B; Liu C; Guo J; Xiao GG
Cancer Cell Int; 2020; 20():457. PubMed ID: 32973402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]